TERMINAL
HEALTHCARE2/27/2026 • LIVE

Charles River Laboratories (CRL)

Charles River Laboratories (CRL) is a healthcare company operating in diagnostics & research. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

PRICE
$175.46
+4.71% today
RISK
VERY HIGH

Key Metrics

MARKET CAP
$8.64B
P/E RATIO
N/A
BETA
1.62
More volatile
DIV YIELD
N/A
52W HIGH
$228.88
52W LOW
$91.86
VOLATILITY
57.1%
30d annualized

Price Performance

30-DAY PRICE CHART

$219.53 → $175.46-20.07%
30 days agoToday

1-YEAR PERFORMANCE

$165.31 → $175.46+6.1%
$129$163$198FebMarAprMayJunJulAugSepOctNovDecJan
CRL | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRICCRLSECTOR AVGVS SECTOR
Beta1.620.85More volatile
30d Volatility57.1%22%Higher risk

TOP HEALTHCARE PEERS

UNHJNJPFE

Competitors Analysis

Compare CRL's key metrics against its main healthcare sector competitors.

COMPANYPRICEMARKET CAPSECTOR
CRL(You are here)
$175.46$8.64BHealthcare—
UNH$286.66$259.67BHealthcareVIEW →
JNJ$243.47$586.74BHealthcareVIEW →
PFE$27.10$154.08BHealthcareVIEW →
Click on a competitor to view their full analysis

Technical Analysis

Charles River Laboratories is currently trading at $175.46, which is 23.3% below its 52-week high. With a beta of 1.62, the stock shows higher sensitivity to market movements.

RSI (14)NEUTRAL
30-DAY TRENDBEARISH
VOLUME1.4M(Above avg)

Frequently Asked Questions

Is CRL a good buy right now?

Charles River Laboratories operates in the Healthcare sector. Current risk level is Very High based on 57.1% volatility.

Does CRL pay dividends?

Charles River Laboratories does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is CRL?

With 30-day annualized volatility of 57.1% and beta of 1.62,CRL is classified as Very High risk. Expect larger swings than the broader market during volatile periods.

Related Assets

LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.

Track CRL Live

Add Charles River Laboratories to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL
Last updated: 2/27/2026, 2:03:56 PM